BSE filing, NSE: AMARDEE. Summary written from the filing by ALFA Finder's alert engine.
Amerise Biosciences Ltd: key numbers
- Share price
- ₹0.84
- Market cap
- ₹5.55 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- -105.1×Sector 26.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amerise Biosciences Ltd
All →Amerise Biosciences Board Meeting Date
Amerise Biosciences will hold a board meeting on 30 October 2026 to consider Q2 and H1 FY27 unaudited results. This is an advance notice of a future meeting with no financial figures disclosed.
Amerise Biosciences Other Announcement
Amerise Biosciences Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Limited conducted its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements and the appointment of a new Wholetime Director and CFO.
Amerise Biosciences Annual Report
Amerise Biosciences has submitted its Annual Report for the financial year 2024-25. The company scheduled its 41st Annual General Meeting for September 24, 2026.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Ltd has submitted the notice for its 41st Annual General Meeting, scheduled to be held on September 24, 2026.
Amerise Biosciences Capital Structure Change
Snehjeev Ventures Private Limited and PACs acquired 76,725 equity shares of Amerise Biosciences Ltd. The acquisition increases their aggregate stake from 10.92% to 11.04%.
Other board meeting date announcements
All →Shlokka Dyes Board Meeting Date
Shlokka Dyes scheduled a board meeting for November 3, 2026 to consider half-year results and fund-raising. Agenda items are proposed and subject to approvals.
Trom Industries Board Meeting Date
TROM Industries Limited has scheduled a board meeting on 03-Nov-2026 to consider unaudited half-yearly standalone results for the period ended September 2026. The trading window closes from 01-Oct-2026 until 05-Nov-2026.
Archit Organosys Board Meeting Date
Archit Organosys will hold a board meeting on November 4, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026.
Ovobel Foods Board Meeting Date
Ovobel Foods will hold a board meeting on November 6, 2026 to consider unaudited results for the quarter ended September 2026. The trading window stays closed until 48 hours after the results announcement.
GNG Electronics Board Meeting Date
GNG Electronics will hold a board meeting on 3 November 2026 to consider unaudited half-year results. The trading window stays closed until 5 November 2026.
Arrowhead Seperation Engineering Board Meeting Date
Arrowhead Separation Engineering schedules a board meeting on November 3, 2026 to approve unaudited half-year results. The trading window stays closed until 48 hours after the meeting.